This case-control study demonstrates that lower circulating IGF-1 levels are strongly associated with poor glycemic control in geriatric patients with T2DM, and are linked to greater insulin resistance, longer disease duration, inflammation (elevated TNF-α), and adverse lipid profiles. Here, IGF1 is linked to Insulin resistance.